What Researchers Did
The researchers tested a device called vaporous hyperoxia therapy (VHT), added to standard wound care, in 36 people with long-standing diabetic foot ulcers that had not healed with standard care alone.
What They Found
In this study of 36 people with chronic diabetic foot ulcers, the group that met and kept up compliance had an 83% ulcer closure rate within 20 weeks when VHT was added to standard wound care. The ulcers were on average 11 months old and over 3 cm2 in size, and were Wagner grade 2 or 3. Treatment was twice-weekly VHT plus wound debridement, with follow-up until closure, 20 weeks, or 40 treatments. The average time to closure was 9.4 weeks. The authors compared this with a historical healing rate of 30.9% for standard wound care across all wounds, and described VHT as raising healing rates 2.85 times.
What This Means for Canadian Patients
The abstract describes a topical mist and oxygen treatment applied to the wound, not hyperbaric oxygen therapy given in a chamber. It says the authors also aimed to compare VHT with hyperbaric oxygen therapy, but it reports no results for that comparison. People with diabetic foot ulcers should talk with their wound care team about what options suit them.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The abstract describes a single group of 36 people with no randomized control group, and the 83% result applies only to those who stayed compliant, so the comparison with a historical healing rate for all wounds cannot show that VHT caused the improvement.